Cost-of-Illness and Treatment Patterns of Gynecologic Cancer in the United States: An Empirical Analysis Based on MEPS Database 2007-2014

Cost-of-Illness and Treatment Patterns of Gynecologic Cancer in the United States: An Empirical Analysis Based on MEPS Database 2007-2014

Bibliographic Details
Main Author:	Yue, Xiaomeng
Language:	English
Published:	University of Cincinnati / OhioLINK 2017
Subjects:	Pharmaceuticals
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=ucin1505207327559448

Similar Items

Intellectual Property and Pharmaceutical Prices in the United States
by: Gilbert Berdine
Published: (2015-07-01)

Effects of a price cut reform on the cost and utilization of antidiabetic drugs in Korea: a national health insurance database study
by: Hae Sun Suh, et al.
Published: (2018-06-01)

Cost of illness of hyponatremia in the United States
by: Paramore Clark, et al.
Published: (2006-05-01)

An Assessment of the need of pharmaceutical services in the intensive care unit and high care unit of Steve Biko Academic hospital
by: Bronkhorst, Elmien.
Published: (2014)

Danish Gynecological Cancer Database
by: Sørensen SM, et al.
Published: (2016-10-01)

Medication Patterns and Comparative Effectiveness Research of Biologic Disease-modifying Antirheumatic Drugs in Children Newly Diagnosed with Juvenile Idiopathic Arthritis using Electronic Medical Records
by: Yue, Xiaomeng
Published: (2020)

Laboratorios Andrómaco: Origins of the First Subsidiary of a Spanish Pharmaceutical Multinational in the United States (1928–1946)
by: Paloma Fernández Pérez
Published: (2016-07-01)

Analyzing Unquantifiable Costs of MEP Construction Projects for High-Tech Fabs
by: 陳政安
Published: (2019)

Conflict detection in 3D MEP coordination : tools, constraints and cost
by: Subramanian, Ganesh
Published: (2010)

Burden of illness and costs associated with eosinophilic granulomatosis with polyangiitis: Evidence from a managed care database in the United States
by: Bell, C.F, et al.
Published: (2021)

Pharmaceuticals in the Built and Natural Water Environment of the United States
by: Randhir P. Deo, et al.
Published: (2013-09-01)

A Comparison of Pharmaceutical Products Obtained from the United States and Mexico
by: Goetz, Kristen, et al.
Published: (2007)

Pattern of Mortality Due to Poisoning by Drugs and Chemical Agents in Hamadan, Iran, 2005-2007
by: S. Afzali, et al.
Published: (2008-07-01)

Pattern of Mortality Due to Poisoning by Drugs and Chemical Agents in Hamadan, Iran, 2005-2007
by: S Afzali, et al.
Published: (2008-06-01)

Looking at Ankara from Strasbourg: An Empirical Assessment of MEPs' Voting on and Framing of Turkey
by: Stefano Braghiroli
Published: (2013-12-01)

Novel Thogotovirus Associated with Febrile Illness and Death, United States, 2014
by: Olga I. Kosoy, et al.
Published: (2015-05-01)

Monetary policy and transaction costs: Empirical analysis of consumption function for the United States of America (1988–2014)
by: Carlos Eduardo Gomes, et al.
Published: (2020-01-01)

Studies on louping-ill virus vaccine
by: Shaw, Barbara Ann
Published: (1981)

Revisiting the public health implications of the United States–Mexico– Canada agreement
by: Tolulope Anthony Adekola
Published: (2020-06-01)

Controversial advertising of medicines. A comparison between Poland and the United States
by: Marta Makowska
Published: (2018-07-01)

The Economic Burden of Opioid Poisoning in the United States and Determinants of Increased Costs in Opioid Poisoning
by: Inocencio, Timothy
Published: (2012)

Benchmarking clinical pharmacy services in the United Arab Emirates with United States of America and Sweden
by: Rand Haider Al Zahawi, et al.
Published: (2021-11-01)

Distinct Amino Acid Availability-Dependent Regulatory Mechanisms of MepS and MepM Levels in Escherichia coli
by: Yung Jae Kim, et al.
Published: (2021-06-01)

COST EFFECTIVENESS OF WARFARIN IN ANTICOAGULANT CLINIC AFTER INTRODUCTION OF DABIGATRAN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION PATIENTS IN THE UNITED STATES
by: Alhazami, Mai
Published: (2015)

The Impact of Health Insurance Status on Healthcare Resource Utilization and Out-of-Pocket Costs in Patients with Multiple Sclerosis in the U.S.A.
by: Elsisi, Zizi
Published: (2020)

ECONOMIC IMPACT OF WASTE IN PRESCRIBING, DISPENSING, AND MEDICATION CONSUMPTION IN THE UNITED STATES
by: Almanie, Sarah
Published: (2015)

Evacuation of Critically Ill Obstetric and Gynecological Patients
by: G. V. Gritsan, et al.
Published: (2008-10-01)

Psychoactive drug advertising: a comparison of technical information from three countries: Brazil, United States and United Kingdom
by: Patricia de Carvalho Mastroianni, et al.

Cost-consequence analysis of Pharmaceutical Care program for systemic arterial hypertension in the public health system in Brazil
by: Maurílio de Souza Cazarim, et al.
Published: (2018-02-01)

The Accuracy of Reported Insurance Status in the MEPS
by: Steven C. Hill
Published: (2007-11-01)

Cost analysis of robot families
by: Björkman, Martin
Published: (2010)

The Pharmaceutical Industry's Effect on Rheumatologists' Patterns of Care
by: Bailey, Frank
Published: (2016)

Biochemical and pharmacological studies on blood platelets and erythocytes in affective illness
by: Docherty, Maureen
Published: (1981)

Design and Implementation of a Pharmaceutical Inventory Database Management System
by: Sama Salam Samaan
Published: (2017-03-01)

Pharmacoeconomic Aspects of Low Back Pain Treatment: Cost of Illness Study in the Republic of Serbia
by: Matija J. Radoičić, et al.
Published: (2019-04-01)

Ambulatory Care Pharmacy in the United States
by: Calhoun, McKenzie L.
Published: (2017)

Predictive Modeling Using a Nationally Representative Database to Identify Patients at Risk of Developing Microalbuminuria
by: Villa Zapata, Lorenzo Andrés
Published: (2014)

A CONTENT ANALYSIS OF THE MISSION STATEMENTS OF IRAN, TURKEY, INDIA AND UNITED STATES PHARMACEUTICAL COMPANIES
by: Shahriar AZIZI, et al.
Published: (2014-06-01)

Publications of Walailak University from 2007 to 2014 in ISI, SCOPUS and TCI Databases
by: Chitnarong SIRISATHITKUL, et al.
Published: (2015-07-01)

Evolution of GDP and its impact on the pharmaceutical sector of Ecuador (2007-2016)
by: Cristina Pérez, et al.
Published: (2018-03-01)

Cannot write session to /tmp/vufind_sessions/sess_d5chor0tr8i4vas34erhs2qfm4